Owens & Minor is a global healthcare logistics company that specializes in the distribution of medical supplies and products to hospitals, healthcare providers, and other organizations within the healthcare industry
The company provides a range of services, including inventory management, supply chain solutions, and the development of customized healthcare products, ensuring that healthcare providers have timely access to the essential medical items needed to deliver quality patient care. By leveraging technology and comprehensive logistics capabilities, Owens & Minor aims to enhance the efficiency of healthcare operations and improve overall patient outcomes.
Owens & Minor Q3 2024 highlights include a 5% sales increase to $2.72 billion, adjusted EPS of $0.42, and Patient Direct revenue growth led by diabetes and sleep supplies.
Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers.
Owens & Minor reported Q2 2024 adjusted EPS of $0.36, beating consensus. Sales rose to $2.671 billion, driven by growth in diabetes and sleep supplies. The company reaffirms 2024 revenue guidance of $10.5 billion-$10.9 billion and expects adjusted EPS of $1.40-$1.70.
Owens & Minor is set to acquire Rotech Healthcare for $1.36 billion, enhancing its Patient Direct segment and aiming for $5 billion in revenue by 2028. The deal includes anticipated tax benefits and significant synergy opportunities.
Jim Cramer has highlighted the potential benefits for U.S. automakers, particularly Ford and General Motors, following the Biden administration's decision to impose substantial tariffs on Chinese imports.
Owens & Minor impresses with Q1 results: adjusted EPS of $0.19, and sales of $2.61B (up 4% Y/Y). Patient Direct revenue reaches $638M (up 5% Y/Y). CEO Edward Pesicka highlights growth strategies and reaffirms 2024 revenue guidance of $10.5-$10.9 billion and adjusted EPS of $1.40-$1.70.
